文献速递乳腺乳腺X线

全球对比增强乳腺摄影专家中心不同报销策略概览——一项调查研究

Overview of different reimbursement strategies among contrast-enhanced mammography (CEM) expert centers on a global level - A survey study.
PubMed 文献 · Eur J Radiol · 2025-07-15

该研究对29名全球对比增强乳腺摄影(CEM)专家乳腺放射科医生发放在线问卷,20人回复。结果显示60%(12/20)医院获得CEM报销,75%(15/20)报告无专门国家报销代码,报销策略异质性大,但65%(13/20)表示报销策略未影响其采用CEM。

要点

  • 60%(12/20)医院获得CEM报销,40%未获报销。
  • 75%(15/20)报告无专门国家CEM报销代码,其中53%(8/15)使用FFDM代码。
  • 65%(13/20)表示报销策略未影响CEM采用。

核心结论

  • CEM报销策略存在显著异质性,多数医院在专门国家报销代码建立前通过替代策略获得全额覆盖。

研究设计与样本

  • 国际在线问卷调查,发放给29名全球CEM专家乳腺放射科医生,20人回复,使用描述性和非参数统计进行分析。

临床应用与阅片要点

  • 60%(12/20)医院获得CEM报销,其中67%(8/12)获全部组件全额报销,75%(9/12)获全部适应症报销。
  • 75%(15/20)报告无专门国家CEM报销代码,其中53%(8/15)使用FFDM代码。
  • 无国家代码的医院中多数缺乏造影剂(60%,9/15)或静脉注射(93.3%,14/15)的单独代码。
  • 45%(9/20)参与者面临报销挑战,但65%(13/20)表示报销策略未影响CEM采用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To perform an international survey among global expert breast radiologists regarding contrast-enhanced mammography (CEM) on the topic of reimbursement strategies.

METHODS: An online questionnaire on CEM reimbursement strategies was distributed to 29 selected global expert breast radiologists regarding CEM. Hospital information, CEM implementation, estimated costs, reimbursement availability, registration and declaration codes, as well as personal opinions on CEM reimbursement, were collected. Replies were analyzed using descriptive and non-parametric statistics.

RESULTS: Twenty out of 29 global expert breast radiologists regarding CEM responded to this survey. All respondents had implemented CEM at their hospitals between 2011 and 2024 and offered CEM for clinical/diagnostic indications, CEM price ranges were lower than MRI at all but two sites. Sixty percent of hospitals (12/20) reported receiving reimbursement for CEM. The remaining 40% declared not receiving reimbursement, citing reasons such as coverage by department budget, lack of dedicated billing code, or absence of reimbursement by the national healthcare system and/or insurance providers. Among the 12 hospitals receiving reimbursement, 67% (8/12) obtained full reimbursement for all components of CEM, and 75% (9/12) for all indications. Reimbursement sources varied by hospital type, with public and university hospitals mainly publicly funded, and private hospitals relying on insurance or patient payments. Most respondents (75%, 15/20) reported that no dedicated national reimbursement code for CEM currently exists. Of these respondents, 53% (8/15) used the FFDM code. Most hospitals lacked separate codes for the contrast medium (60%, 9/15) or its intravenous injection (93.3%, 14/15). Among hospitals without a national code, 73% (11/15) were aware of efforts to establish one. Although nearly half of the participants (45%, 9/20) faced reimbursement challenges, 65% (13/20) stated that reimbursement strategies did not affect their CEM adoption.

CONCLUSION: Substantial heterogeneity in CEM reimbursement strategies exist, with most hospitals securing full coverage through alternative strategies until dedicated national reimbursement codes are established.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sáenz JA, Baltzer PAT, Allajbeu I, et al. Overview of different reimbursement strategies among contrast-enhanced mammography (CEM) expert centers on a global level - A survey study. Eur J Radiol. 2025. PMID: 40682981. doi:10.1016/j.ejrad.2025.112315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。